SGA Global Growth Strategy, an investment management entity, recently disclosed its decision to divest its stake in UnitedHealth Group Incorporated (NYSE:UNH). This strategic move follows a period of underperformance for UNH, which was influenced by shifts in government policies concerning Medicare Advantage programs and a slower recovery in Optum's profitability than initially projected. The firm's first-quarter 2026 investor letter detailed these challenges, highlighting a competitive landscape within the Medicare Advantage market. As a result, SGA aims to redirect its capital into opportunities with higher growth potential, signaling a reevaluation of its investment strategy in the healthcare sector.
SGA Global Growth Fund's Strategic Exit from UnitedHealth: A Detailed Analysis
In the initial quarter of 2026, Sustainable Growth Advisers (SGA), a prominent investment management firm, released its investor letter for its Global Growth Strategy. The report revealed a return of -13.6% (Gross) and -13.8% (Net) for the portfolio, significantly trailing the MSCI ACWI's -3.2% and MSCI ACWI Growth's -7.7% returns. The letter pinpointed artificial intelligence (AI) disruption narratives and geopolitical tensions in the Middle East as major contributors to market volatility during this period, affecting sectors such as software, information services, payments, and insurance.
SGA had maintained a position in UnitedHealth Group Incorporated (NYSE:UNH), a multinational health benefits company headquartered in Eden Prairie, Minnesota, banking on its capacity to manage escalating healthcare costs through its extensive scale and strong pricing power, particularly with its vertically integrated Optum division. The privatization of government-funded senior health plans, specifically Medicare Advantage, was also perceived as a significant growth avenue. However, the stock experienced difficulties throughout 2025 due to operational setbacks and reductions in government payments to Medicare Advantage programs, initiated under the Biden administration.
Despite these challenges, SGA initially held onto its UNH shares, anticipating a repricing of health insurance policies and an improvement in operational efficiency following Stephen Hemsley's return as CEO. Furthermore, the firm believed that a change in administration could be advantageous, given historical Republican support for Medicare privatization. Nevertheless, the Centers for Medicare & Medicaid Services (CMS) released a preliminary rate of merely 0.1% for 2027 during the first quarter, which profoundly disappointed both SGA and the broader market. Although the final rate was subsequently adjusted upward to 2.5%, it still fell short of mid-single-digit expectations and lagged behind cost inflation trends. The latest communications also indicated greater-than-expected membership losses and a slower improvement in Optum's profitability, suggesting a more mature and competitive Medicare Advantage market. Consequently, SGA decided to exit its position in UNH, reallocating its capital to more compelling growth prospects. As of June 16, 2026, UNH closed at $407.65 per share, with a one-month return of 6.35% and a 52-week gain of 32.70%, boasting a market capitalization of $370.205 billion. At the end of the first quarter, 130 hedge fund portfolios held UNH, a decrease from 145 in the preceding quarter.
This strategic divestment by SGA Global Growth Fund highlights the dynamic and often unpredictable nature of investment markets, particularly when influenced by regulatory shifts and evolving competitive landscapes. While UnitedHealth Group remains a significant player in the healthcare industry, SGA's decision underscores the importance for investors to continuously assess market conditions and rebalance portfolios to maximize returns and mitigate risks. It also serves as a reminder that even established companies can face headwinds that necessitate a reevaluation of their long-term growth potential. The move by SGA suggests a pivot towards sectors or companies perceived to offer more robust growth avenues, potentially in emerging areas like AI, reflecting a broader trend among sophisticated investors to seek out next-generation opportunities.
